Kaliappanadar Nellaiappan, Ph.D. is an accomplished scientific leader with over 25 years of experience in drug delivery systems, protein engineering, and biologics development. As Chief Scientific Officer, he leads the company’s scientific strategy, research execution, and technology development.

Dr. Nellaiappan has led the development of numerous therapeutic programs across a wide range of delivery platforms, including nanoparticles, liposomes, micelles, oral biologics, and lipid‑based systems. His experience spans early discovery through IND‑enabling development, with a strong emphasis on formulation science, translational readiness, and manufacturability.

He is a prolific inventor and scientific contributor, with extensive experience in patent development and applied research. Dr. Nellaiappan brings deep technical rigor and strategic insight to advancing scalable, clinically meaningful biologic delivery solutions.